Hepatera
Company

General

About Company
Hepatera is a Russian biotech company focused on developing and bringing safe and effective drugs for liver diseases to the Russian market.

Industry

Sector :

Subsector :

Keywords :

Company Type

For Profit

IPO status

Private

Description

Founded in 2011, Hepatera evaluates promising drug candidates and collaborates with international companies to develop innovative drugs like Myrcludex B, which targets chronic viral hepatitis B and D. As a resident of the Biomedical cluster of Skolkovo innovation center since December 2011, Hepatera is committed to providing individuals with better healthcare outcomes through the prevention and treatment of liver diseases.
Contacts

Contact Email

Phone number

Similar Companies
1000
AngioChem

AngioChem

AngioChem develops drugs that can treat brain diseases by crossing the blood-brain barrier.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Dorval, QC, Canada

total rounds

5

total raised

$21.31M
PCOVERY

PCOVERY

Pcovery is a drug discovery company specializing in developing a new class of anti-fungals for serious invasive fungal infections.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Copenhagen, Denmark
Dolthera GmbH

Dolthera GmbH

Dolthera GmbH is a biopharmaceutical company developing nucleic-acid-based anti-inflammatory drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Martinsried, 82152 Planegg, Germany

total rounds

2

total raised

$18.87M
Lipideon Biotechnology AG

Lipideon Biotechnology AG

Lipideon Biotechnology AG develops drugs to treat arteriosclerosis and related cardiovascular diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Zürich, Switzerland

Financials

Co-Investors

Activity

Recent News
0